You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Drug

Published Date: 13 Jun 2024

Revision Summary:
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Jun 2024
Regimen
Published Date: 13 Jun 2024
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Interactions, Pregnancy/Lactation, and Monitoring sections

Updated
Jun 2024
Drug

Published Date: 13 Jun 2024

Revision Summary:
Drug Monograph: Updated Adverse Effects, Dosing, Special Precautions, and Monitoring sections
Updated
Jun 2024
Drug

Published Date: 13 Jun 2024

Revision Summary:
Drug Monograph: Modified Interactions and Monitoring sections
Patient Info Sheet EN: Modified "What should I do before I have this medication?" section
Patient Info Sheet FR: Updated "What should I do before I have this medication?" section (Mise à jour de la section « Qu’est-ce que je dois faire avant d’avoir ce médicament? »)
Updated
Jun 2024
Drug

Published Date: 10 Jun 2024

Revision Summary:
Drug Monograph: Modified Pharmacokinetics, Dosage in hepatic impairment, Dosage in renal impairment, Dosage in the elderly, Administration guidelines, Pregnancy/lactation, and Interactions sections
Patient Info Sheet EN: Revised/Updated information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Intent: Palliative
Revision Summary:

Regimen Monograph: Removed PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024
Regimen
Published Date: 03 Jun 2024
Cancer Type:
Gastrointestinal, 
Neuroendocrine (GI), 
Lung, 
Neuroendocrine (Lung)
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated PEBC guideline link

Updated
Jun 2024

Pages